
PG Valuation
Procter & Gamble Co
PG Relative Valuation
PG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PG is overvalued; if below, it's undervalued.
Historical Valuation
Procter & Gamble Co (PG) is now in the Undervalued zone, suggesting that its current forward PE ratio of 20.71 is considered Undervalued compared with the five-year average of 23.86. The fair price of Procter & Gamble Co (PG) is between 162.67 to 176.76 according to relative valuation methord. Compared to the current price of 146.98 USD , Procter & Gamble Co is Undervalued By 9.65%.
Relative Value
Fair Zone
162.67-176.76
Current Price:146.98
9.65%
Undervalued
20.71
PE
1Y
3Y
5Y
Trailing
Forward
15.04
EV/EBITDA
Procter & Gamble Co. (PG) has a current EV/EBITDA of 15.04. The 5-year average EV/EBITDA is 17.09. The thresholds are as follows: Strongly Undervalued below 15.38, Undervalued between 15.38 and 16.23, Fairly Valued between 17.95 and 16.23, Overvalued between 17.95 and 18.81, and Strongly Overvalued above 18.81. The current Forward EV/EBITDA of 15.04 falls within the Strongly Undervalued range.
17.31
EV/EBIT
Procter & Gamble Co. (PG) has a current EV/EBIT of 17.31. The 5-year average EV/EBIT is 19.71. The thresholds are as follows: Strongly Undervalued below 17.65, Undervalued between 17.65 and 18.68, Fairly Valued between 20.75 and 18.68, Overvalued between 20.75 and 21.78, and Strongly Overvalued above 21.78. The current Forward EV/EBIT of 17.31 falls within the Strongly Undervalued range.
146.98
PS
Procter & Gamble Co. (PG) has a current PS of 146.98. The 5-year average PS is 5.41. The thresholds are as follows: Strongly Undervalued below -19.09, Undervalued between -19.09 and -6.84, Fairly Valued between 17.65 and -6.84, Overvalued between 17.65 and 29.90, and Strongly Overvalued above 29.90. The current Forward PS of 146.98 falls within the Strongly Overvalued range.
17.77
P/OCF
Procter & Gamble Co. (PG) has a current P/OCF of 17.77. The 5-year average P/OCF is 19.21. The thresholds are as follows: Strongly Undervalued below 16.88, Undervalued between 16.88 and 18.04, Fairly Valued between 20.37 and 18.04, Overvalued between 20.37 and 21.53, and Strongly Overvalued above 21.53. The current Forward P/OCF of 17.77 falls within the Undervalued range.
21.59
P/FCF
Procter & Gamble Co. (PG) has a current P/FCF of 21.59. The 5-year average P/FCF is 23.58. The thresholds are as follows: Strongly Undervalued below 20.71, Undervalued between 20.71 and 22.15, Fairly Valued between 25.01 and 22.15, Overvalued between 25.01 and 26.44, and Strongly Overvalued above 26.44. The current Forward P/FCF of 21.59 falls within the Undervalued range.
Procter & Gamble Co (PG) has a current Price-to-Book (P/B) ratio of 6.54. Compared to its 3-year average P/B ratio of 7.70 , the current P/B ratio is approximately -15.07% higher. Relative to its 5-year average P/B ratio of 7.66, the current P/B ratio is about -14.63% higher. Procter & Gamble Co (PG) has a Forward Free Cash Flow (FCF) yield of approximately 4.35%. Compared to its 3-year average FCF yield of 3.94%, the current FCF yield is approximately 10.52% lower. Relative to its 5-year average FCF yield of 4.11% , the current FCF yield is about 5.87% lower.
6.54
P/B
Median3y
7.70
Median5y
7.66
4.35
FCF Yield
Median3y
3.94
Median5y
4.11
Competitors Valuation Multiple
The average P/S ratio for PG's competitors is 81.35, providing a benchmark for relative valuation. Procter & Gamble Co Corp (PG) exhibits a P/S ratio of 146.98, which is 80.68% above the industry average. Given its robust revenue growth of 2.99%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of PG decreased by 18.01% over the past 1 year. The primary factor behind the change was an increase in Margin Expansion from 18.34 to 21.36.
The secondary factor is the Revenue Growth, contributed 2.99%to the performance.
Overall, the performance of PG in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch

ABBV
AbbVie Inc
219.160
USD
+0.05%

UNH
UnitedHealth Group Inc
324.210
USD
+0.82%

CRM
Salesforce Inc
239.880
USD
+0.25%

COST
Costco Wholesale Corp
922.740
USD
-0.09%

MCD
McDonald's Corp
299.660
USD
+0.42%

PFE
Pfizer Inc
24.430
USD
-1.69%

ADBE
Adobe Inc
326.950
USD
-0.12%

TMO
Thermo Fisher Scientific Inc
572.410
USD
+1.14%

KO
Coca-Cola Co
70.550
USD
+2.16%

PEP
PepsiCo Inc
142.950
USD
+0.97%
FAQ
Is Procter & Gamble Co (PG) currently overvalued or undervalued?
Procter & Gamble Co (PG) is now in the Undervalued zone, suggesting that its current forward PE ratio of 20.71 is considered Undervalued compared with the five-year average of 23.86. The fair price of Procter & Gamble Co (PG) is between 162.67 to 176.76 according to relative valuation methord. Compared to the current price of 146.98 USD , Procter & Gamble Co is Undervalued By 9.65% .







